This small open-label trial tests a bundled regional plus systemic opioid-free protocol in mastectomy, offering stewardship-relevant signals but limited ability to attribute benefit to any single component.
📅 Journal publication: Oct-Dec 2026(online Oct 17, 2026)·Last updated: Nov 19, 2026
Ultrasound-guided blocks might eliminate opioids in surgery.
This study explores an opioid-free analgesia approach for breast cancer surgery, potentially reducing opioid-related side effects. Group B achieved zero perioperative opioid use with superior pain control and recovery scores compared to Group A. Eliminating opioids in modified radical mastectomy using this method could enhance recovery protocols, though findings are in a specific context. Opioid-free anesthesia using ultrasound-guided costotransverse block with adjuvants may improve outcomes in breast cancer surgery.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Banish TM, Sethi P, Mathur R, Dang D, Kaur M, Kumari K, Sharma N, Bhatia PK
Citation:Banish TM, Sethi P, Mathur R, et al. Ultrasound-guided costotransverse block with systemic adjuvants for complete opioid-free breast cancer surgery: A randomized controlled trial. Journal of anaesthesiology, clinical pharmacology. 2026;42(4):557-564. doi:10.4103/joacp.joacp_746_25